These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 24588614)

  • 1. Alanine analogues of [D-Trp]CJ-15,208: novel opioid activity profiles and prevention of drug- and stress-induced reinstatement of cocaine-seeking behaviour.
    Aldrich JV; Senadheera SN; Ross NC; Reilley KA; Ganno ML; Eans SE; Murray TF; McLaughlin JP
    Br J Pharmacol; 2014 Jul; 171(13):3212-22. PubMed ID: 24588614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel opioid cyclic tetrapeptides: Trp isomers of CJ-15,208 exhibit distinct opioid receptor agonism and short-acting κ opioid receptor antagonism.
    Ross NC; Reilley KJ; Murray TF; Aldrich JV; McLaughlin JP
    Br J Pharmacol; 2012 Feb; 165(4b):1097-108. PubMed ID: 21671905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The macrocyclic tetrapeptide [D-Trp]CJ-15,208 produces short-acting κ opioid receptor antagonism in the CNS after oral administration.
    Eans SO; Ganno ML; Reilley KJ; Patkar KA; Senadheera SN; Aldrich JV; McLaughlin JP
    Br J Pharmacol; 2013 May; 169(2):426-36. PubMed ID: 23425081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenylalanine Stereoisomers of CJ-15,208 and [d-Trp]CJ-15,208 Exhibit Distinctly Different Opioid Activity Profiles.
    Brice-Tutt AC; Senadheera SN; Ganno ML; Eans SO; Khaliq T; Murray TF; McLaughlin JP; Aldrich JV
    Molecules; 2020 Sep; 25(17):. PubMed ID: 32887303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multifunctional opioid receptor agonism and antagonism by a novel macrocyclic tetrapeptide prevents reinstatement of morphine-seeking behaviour.
    Brice-Tutt AC; Wilson LL; Eans SO; Stacy HM; Simons CA; Simpson GG; Coleman JS; Ferracane MJ; Aldrich JV; McLaughlin JP
    Br J Pharmacol; 2020 Sep; 177(18):4209-4222. PubMed ID: 32562259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unexpected opioid activity profiles of analogues of the novel peptide kappa opioid receptor ligand CJ-15,208.
    Aldrich JV; Kulkarni SS; Senadheera SN; Ross NC; Reilley KJ; Eans SO; Ganno ML; Murray TF; McLaughlin JP
    ChemMedChem; 2011 Sep; 6(9):1739-45. PubMed ID: 21761566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tryptophan Substitution in CJ-15,208 (
    Scherrer KH; Eans SO; Medina JM; Senadheera SN; Khaliq T; Murray TF; McLaughlin JP; Aldrich JV
    Pharmaceuticals (Basel); 2023 Aug; 16(9):. PubMed ID: 37765026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, Synthesis, and Characterization of the Macrocyclic Tetrapeptide
    Ferracane MJ; Brice-Tutt AC; Coleman JS; Simpson GG; Wilson LL; Eans SO; Stacy HM; Murray TF; McLaughlin JP; Aldrich JV
    ACS Chem Neurosci; 2020 May; 11(9):1324-1336. PubMed ID: 32251585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The macrocyclic peptide natural product CJ-15,208 is orally active and prevents reinstatement of extinguished cocaine-seeking behavior.
    Aldrich JV; Senadheera SN; Ross NC; Ganno ML; Eans SO; McLaughlin JP
    J Nat Prod; 2013 Mar; 76(3):433-8. PubMed ID: 23327691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An analog of [d-Trp]CJ-15,208 exhibits kappa opioid receptor antagonism following oral administration and prevents stress-induced reinstatement of extinguished morphine conditioned place preference.
    Brice-Tutt AC; Eans SO; Yakovlev D; Aldrich JV; McLaughlin JP
    Pharmacol Biochem Behav; 2022 Jun; 217():173405. PubMed ID: 35584724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Buprenorphine Analogue BU10119 Attenuates Drug-Primed and Stress-Induced Cocaine Reinstatement in Mice.
    Hillhouse TM; Olson KM; Hallahan JE; Rysztak LG; Sears BF; Meurice C; Ostovar M; Koppenhaver PO; West JL; Jutkiewicz EM; Husbands SM; Traynor JR
    J Pharmacol Exp Ther; 2021 Sep; 378(3):287-299. PubMed ID: 34183434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Locus coeruleus kappa-opioid receptors modulate reinstatement of cocaine place preference through a noradrenergic mechanism.
    Al-Hasani R; McCall JG; Foshage AM; Bruchas MR
    Neuropsychopharmacology; 2013 Nov; 38(12):2484-97. PubMed ID: 23787819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel ligands lacking a positive charge for the delta- and mu-opioid receptors.
    Schiller PW; Berezowska I; Nguyen TM; Schmidt R; Lemieux C; Chung NN; Falcone-Hindley ML; Yao W; Liu J; Iwama S; Smith AB; Hirschmann R
    J Med Chem; 2000 Feb; 43(4):551-9. PubMed ID: 10691681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opiate aromatic pharmacophore structure-activity relationships in CTAP analogues determined by topographical bias, two-dimensional NMR, and biological activity assays.
    Bonner GG; Davis P; Stropova D; Edsall S; Yamamura HI; Porreca F; Hruby VJ
    J Med Chem; 2000 Feb; 43(4):569-80. PubMed ID: 10691683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stress-Induced Reinstatement of Nicotine Preference Requires Dynorphin/Kappa Opioid Activity in the Basolateral Amygdala.
    Nygard SK; Hourguettes NJ; Sobczak GG; Carlezon WA; Bruchas MR
    J Neurosci; 2016 Sep; 36(38):9937-48. PubMed ID: 27656031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reinstatement of cocaine place-conditioning prevented by the peptide kappa-opioid receptor antagonist arodyn.
    Carey AN; Borozny K; Aldrich JV; McLaughlin JP
    Eur J Pharmacol; 2007 Aug; 569(1-2):84-9. PubMed ID: 17568579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological characterization and therapeutic potential for the treatment of opioid abuse with ATPM-ET, an N-ethyl substituted aminothiazolomorphinan with κ agonist and μ agonist/antagonist activity.
    Sun JF; Wang YH; Chai JR; Li FY; Hang A; Lu G; Tao YM; Cheng Y; Chi ZQ; Neumeyer JL; Zhang A; Liu JG; Wang YJ
    Eur J Pharmacol; 2014 Oct; 740():455-63. PubMed ID: 24998879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a robust, sensitive and selective liquid chromatography-tandem mass spectrometry assay for the quantification of the novel macrocyclic peptide kappa opioid receptor antagonist [D-Trp]CJ-15,208 in plasma and application to an initial pharmacokinetic study.
    Khaliq T; Williams TD; Senadheera SN; Aldrich JV
    J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Aug; 1028():11-15. PubMed ID: 27318293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of the kappa opioid receptor antagonist, norbinaltorphimine, on stress and drug-induced reinstatement of nicotine-conditioned place preference in mice.
    Jackson KJ; McLaughlin JP; Carroll FI; Damaj MI
    Psychopharmacology (Berl); 2013 Apr; 226(4):763-8. PubMed ID: 22526543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of new deltorphin analogues on reinstatement of cocaine-induced conditioned place preference in rats.
    Kotlinska JH; Gibula-Bruzda E; Pachuta A; Kunce D; Witkowska E; Chung NN; Schiller PW; Izdebski J
    Behav Pharmacol; 2010 Oct; 21(7):638-48. PubMed ID: 20729716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.